Correlation Between Puma Biotechnology and Sonnet Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Puma Biotechnology and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Puma Biotechnology and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and Sonnet Biotherapeutics.
Diversification Opportunities for Puma Biotechnology and Sonnet Biotherapeutics
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Puma and Sonnet is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and Sonnet Biotherapeutics go up and down completely randomly.
Pair Corralation between Puma Biotechnology and Sonnet Biotherapeutics
Given the investment horizon of 90 days Puma Biotechnology is expected to generate 0.77 times more return on investment than Sonnet Biotherapeutics. However, Puma Biotechnology is 1.3 times less risky than Sonnet Biotherapeutics. It trades about 0.02 of its potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about -0.29 per unit of risk. If you would invest 297.00 in Puma Biotechnology on September 14, 2024 and sell it today you would lose (5.00) from holding Puma Biotechnology or give up 1.68% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Puma Biotechnology vs. Sonnet Biotherapeutics Holding
Performance |
| Timeline |
| Puma Biotechnology |
| Sonnet Biotherapeutics |
Puma Biotechnology and Sonnet Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Puma Biotechnology and Sonnet Biotherapeutics
The main advantage of trading using opposite Puma Biotechnology and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
| Sonnet Biotherapeutics vs. Puma Biotechnology | Sonnet Biotherapeutics vs. Iovance Biotherapeutics | Sonnet Biotherapeutics vs. Day One Biopharmaceuticals | Sonnet Biotherapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |